Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN.

N Engl J Med. 2010 Nov 4;363(19):1801-11. doi: 10.1056/NEJMoa1001671.

2.

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S.

Lancet. 2013 Jan 12;381(9861):125-32. doi: 10.1016/S0140-6736(12)61134-9. Epub 2012 Nov 14. Erratum in: Lancet. 2013 Jan 12;381(9861):116.

PMID:
23158522
3.

Rapamycin and rapalogs for tuberous sclerosis complex.

Sasongko TH, Ismail NF, Zabidi-Hussin Z.

Cochrane Database Syst Rev. 2016 Jul 13;7:CD011272. doi: 10.1002/14651858.CD011272.pub2. Review.

PMID:
27409709
4.

[Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].

Mateos-González ME, López-Laso E, Vicente-Rueda J, Camino-León R, Fernández-Ramos JA, Baena-Gómez MA, Peña-Rosa MJ.

Rev Neurol. 2014 Dec 1;59(11):497-502. Spanish.

5.

Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis.

Trelinska J, Dachowska I, Kotulska K, Baranska D, Fendler W, Jozwiak S, Mlynarski W.

Pediatr Blood Cancer. 2015 Apr;62(4):616-21. doi: 10.1002/pbc.25368. Epub 2015 Jan 3.

PMID:
25557360
6.

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.

Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Anak O, Niolat J, Jozwiak S.

Lancet Oncol. 2014 Dec;15(13):1513-20. doi: 10.1016/S1470-2045(14)70489-9. Epub 2014 Nov 10.

PMID:
25456370
7.

Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Kotulska K, Chmielewski D, Borkowska J, Jurkiewicz E, Kuczyński D, Kmieć T, Łojszczyk B, Dunin-Wąsowicz D, Jóźwiak S.

Eur J Paediatr Neurol. 2013 Sep;17(5):479-85. doi: 10.1016/j.ejpn.2013.03.002. Epub 2013 Apr 6.

PMID:
23567018
8.

Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex.

Fukumura S, Watanabe T, Takayama R, Minagawa K, Tsutsumi H.

J Child Neurol. 2015 Aug;30(9):1192-5. doi: 10.1177/0883073814544703. Epub 2014 Aug 19.

PMID:
25143481
9.

Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.

Cardamone M, Flanagan D, Mowat D, Kennedy SE, Chopra M, Lawson JA.

J Pediatr. 2014 May;164(5):1195-200. doi: 10.1016/j.jpeds.2013.12.053. Epub 2014 Feb 8.

PMID:
24518170
10.

Everolimus for subependymal giant cell astrocytoma: 5-year final analysis.

Franz DN, Agricola K, Mays M, Tudor C, Care MM, Holland-Bouley K, Berkowitz N, Miao S, Peyrard S, Krueger DA.

Ann Neurol. 2015 Dec;78(6):929-38. doi: 10.1002/ana.24523. Epub 2015 Nov 9.

11.

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Fogarasi A, De Waele L, Bartalini G, Jozwiak S, Laforgia N, Verhelst H, Petrak B, Pedespan JM, Witt O, Castellana R, Crippa S, Gislimberti G, Gyorsok Z.

BMC Neurol. 2016 Aug 8;16:126. doi: 10.1186/s12883-016-0658-4.

12.

Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.

Cheng S, Hawkins C, Taylor MD, Bartels U.

Pediatr Neurol. 2015 Sep;53(3):238-242.e1. doi: 10.1016/j.pediatrneurol.2015.05.020. Epub 2015 Jun 14.

PMID:
26173783
13.

Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Franz DN, Agricola KD, Tudor CA, Krueger DA.

J Child Neurol. 2013 May;28(5):602-7. doi: 10.1177/0883073812449904. Epub 2012 Jul 17.

PMID:
22805244
14.

Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.

Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domańska-Pakieła D, Jóźwiak S.

Pediatr Neurol. 2014 Apr;50(4):307-12. doi: 10.1016/j.pediatrneurol.2013.12.004. Epub 2013 Dec 10.

PMID:
24507694
16.

Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex.

Cappellano AM, Senerchia AA, Adolfo F, Paiva PM, Pinho R, Covic A, Cavalheiro S, Saba N.

Childs Nerv Syst. 2013 Dec;29(12):2301-5. doi: 10.1007/s00381-013-2170-0. Epub 2013 Jun 7.

PMID:
23743818
17.

Everolimus tablets for patients with subependymal giant cell astrocytoma.

Turner SG, Peters KB, Vredenburgh JJ, Desjardins A, Friedman HS, Reardon DA.

Expert Opin Pharmacother. 2011 Oct;12(14):2265-9. doi: 10.1517/14656566.2011.601742. Epub 2011 Aug 1. Review.

18.

Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.

Aguilera D, Flamini R, Mazewski C, Schniederjan M, Hayes L, Boydston W, Castellino RC, MacDonald TJ.

J Pediatr Hematol Oncol. 2014 Oct;36(7):e448-51. doi: 10.1097/MPH.0000000000000005.

19.

Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Józwiak S, Stein K, Kotulska K.

Future Oncol. 2012 Dec;8(12):1515-23. doi: 10.2217/fon.12.146. Review.

PMID:
23231513
20.

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.

Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR.

Ann Neurol. 2006 Mar;59(3):490-8.

PMID:
16453317

Supplemental Content

Support Center